Coloplast As ADR (CLPBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,066,468 | 833,052 | 514,310 | 262,650 | 1,064,328 |
| Depreciation Amortization | 215,189 | 154,382 | 94,819 | 46,871 | 187,566 |
| Accounts receivable | -5,332 | -39,850 | -10,441 | 16,576 | -73,572 |
| Accounts payable and accrued liabilities | -29,472 | -55,517 | -106,531 | -572 | -11,777 |
| Other Working Capital | -116,259 | -148,602 | -129,107 | 24,579 | -150,053 |
| Other Operating Activity | -146,471 | -77,267 | 24,834 | -63,305 | -614,315 |
| Operating Cash Flow | $984,125 | $666,198 | $387,884 | $286,800 | $402,176 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -192,678 | -142,061 | -78,028 | -39,155 | -167,355 |
| Net Acquisitions | 28,435 | 29,203 | 27,091 | 27,437 | 1,163 |
| Purchase Of Investment | -3,110 | -3,194 | -2,963 | -3,001 | -1,890 |
| Purchase Sale Intangibles | -17,920 | -14,906 | -8,466 | -4,287 | -26,172 |
| Other Investing Activity | -17,920 | -14,906 | -8,466 | -4,287 | -26,172 |
| Investing Cash Flow | $-185,273 | $-130,958 | $-62,366 | $-19,006 | $-194,254 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -408,460 | 243,360 | 224,067 | 301,376 | 409,737 |
| Debt Repayment | N/A | N/A | N/A | N/A | -704,899 |
| Common Stock Issued | 3,999 | 4,107 | 3,810 | 4,001 | 72,700 |
| Dividend Paid | -734,280 | -754,112 | -540,554 | -547,450 | -686,288 |
| Other Financing Activity | 370,546 | -32,245 | -20,177 | -9,574 | 688,033 |
| Financing Cash Flow | $-768,195 | $-538,890 | $-332,855 | $-251,647 | $-220,717 |
| Exchange Rate Effect | -7,257 | -5,780 | -988 | 715 | -4,507 |
| Beginning Cash Position | 116,703 | 119,855 | 111,187 | 112,605 | 132,459 |
| End Cash Position | 140,251 | 110,425 | 102,862 | 129,467 | 114,575 |
| Net Cash Flow | $23,548 | $-9,430 | $-8,325 | $16,862 | $-17,884 |
| Free Cash Flow | |||||
| Operating Cash Flow | 984,125 | 666,198 | 387,884 | 286,800 | 402,176 |
| Capital Expenditure | -193,419 | -142,670 | -78,734 | -39,726 | -169,536 |
| Free Cash Flow | 790,706 | 523,528 | 309,150 | 247,074 | 232,640 |